The Future of Machine Learning Within Target Identification: Causality, Reversibility, and Druggability
Open Access
- 3 January 2024
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 115 (4) , 655-657
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- RECOVER identifies synergistic drug combinations in vitro through sequential model optimizationCell Reports Methods, 2023
- Human genetics evidence supports two-thirds of the 2021 FDA-approved drugsNature Reviews Drug Discovery, 2022
- Structure of cytoplasmic ring of nuclear pore complex by integrative cryo-EM and AlphaFoldScience, 2022
- The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humansScience, 2022
- Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seqbioRxiv, 2021
- Rethinking rare disease: longevity-enhancing drug targets through X-linked aneuploidyTrends in Genetics, 2021
- Effective gene expression prediction from sequence by integrating long-range interactionsNature Methods, 2021
- Highly accurate protein structure prediction with AlphaFoldNature, 2021
- Utilizing graph machine learning within drug discovery and developmentBriefings in Bioinformatics, 2021
- FTO Obesity Variant Circuitry and Adipocyte Browning in HumansNew England Journal of Medicine, 2015